Debt to EBITDA ratio Analysis of China SXT Pharma Inc. - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointDebt to EBITDA of SXTC
Mar-23-0.655Very Poor Debt to EBITDA | Mar-22-0.402Very Poor Debt to EBITDA | Growth-62.84% |
Debt to EBITDA Analysis of China SXT Pharma Inc.
| Debt to EBITDA Ratio of SXTC drastically fell by -62.84 % this year. |
| Debt to EBITDA Ratio with value of 0.133 was highest in Year Mar-19 in last Five Years. |
| Debt to EBITDA Ratio with value of -0.655 was lowest in Year Mar-23 in last Five Years. |
| Latest Debt to EBITDA Ratio with value of -0.655 is lower than Average Debt to EBITDA of -0.289 in last five years. |
Other Debt to EBITDA Related Info of SXTC that may interest you.
China SXT Pharma Inc. Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| SXTC | 1.1 | 1.09 | 0.917 % | Drug Manufacturers-Specialty & Generic |
Defination of Debt to EBITDA
The Debt to EBITDA Ratio is a solvency metric that measures the company's ability to meet its debt obligations by earnings before covering its interest, taxes, depreciation, and amortization. more ..
Debt to EBITDA Related Ratios
| CashFlowFromOperationToDebt | DebtToCapital | EVToEBITDA |
Tsr Stability Index
| Very Low Stability Stock | |
FY - Historical Debt to EBITDA of China SXT Pharma Inc.
| Period | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|
| Debt to EBITDA | -0.655 | -0.402 | -0.0167 | -0.502 | 0.133 | 0.219 | 0.180 |
| Change | -62.84 % | -2304.48 % | 96.66 % | -477.80 % | -39.46 % | 21.87 % | -90.96 % |
FY Chart of Debt to EBITDA of China SXT Pharma Inc.
Note : All Data Generated at the End of Trading Hours (EOD Data)